Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06381791
Other study ID # PRO00036811
Secondary ID
Status Recruiting
Phase Phase 1/Phase 2
First received
Last updated
Start date May 24, 2024
Est. completion date December 30, 2027

Study information

Verified date May 2024
Source The Methodist Hospital Research Institute
Contact Haley M Goble, MPH, CRCC
Phone 7134413930
Email hmgoble@houstonmethodist.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the study is to learn if Epidiolex (cannabidiol) works as a additional pain medication in patients who have had orthopedic shoulder surgery. It is also to learn about safe dosages and identify any side effects after surgery. Researchers will compare Epidiolex to a placebo solution to see if Epidiolex lowers pain after shoulder surgery. Participants will: - track their pain and what medications they use every day in a provided pain diary. A researchers will call every seven days to check on the participant and diary. - Complete two short surveys. Once before surgery and once after. - Have bloodwork tested after surgery


Description:

Subjects will be randomized according to their surgery type. They will receive either the Epidiolex cannabidiol in addition to their standard of care pain regimen or a placebo in addition to their standard of care pain regimen. They will be asked to track a pain diary for 2 weeks postoperatively. A member of the research team will conduct a follow-up telephone call on day 7 to assess subjects' drug compliance. Subjects will also be contacted for a safety monitoring call at day 7 and 1 week after completion of treatment in which they will disclose type, severity, onset, and duration of any adverse events. In addition, they will complete a suicidal assessment10 See attached safety screening document. After the 2 weeks, subjects will return the pain diary and vial of CBD/placebo at their postoperative appointment. Subjects will also be asked to complete validated questionnaires via Houston Methodist's Redcap system once before surgery and again at 14 days postop. The surveys are with regards to sleep, activity, and pain and should take no more than 15 minutes to complete. At their standard of care postoperative visit (11-17 days following surgery), another liver panel will be taken and their final safety monitoring screening will be conducted.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 30, 2027
Est. primary completion date December 30, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Undergoing one of the following orthopedic shoulder surgeries: - Total shoulder arthroplasty - Reverse total shoulder arthroplasty - Shoulder hemiarthroplasty - Rotator cuff repair - Receiving standard anesthesia during surgery - If a subject is of reproductive potential, they must be on effective contraception one month prior, during treatment, and one month following treatment. Exclusion Criteria: - Not between the ages of 18-55 years old - History of revision shoulder arthroplasty - History of liver disease or impairment - Are currently taking valproate or clobazam - Are currently taking a moderate/strong CYP3A4 or CYP2C19 inhibitor - Are currently taking a strong CYP3A4 or CYP2C19 inducer - Are currently taking narcotics - History of substance/alcohol abuse - Those currently or previously under the care of a pain management specialist - History of marijuana/cannabidiol (not including topical) regular use within the past 6 months - Allergy related to cannabidiol - Allergy related to sesame seeds - Pregnancy (As part of standard of care, all female participants will be administered a urine pregnancy test prior to surgery. A negative test result is required to participate in the study.) - If you are taking any medications with known risks for suicidal behavior and ideation - If you have a diagnosed psychiatric or sleeping disorder - If you are actively breastfeeding - Patients currently taking central nervous system (CNS) depressants - Patients currently taking other drugs with known hepatotoxicity - Vulnerable populations. Patients taking concomitant medications which are substrate of uridine 5'-diphospho-glucuronosyltransferase 1-9 (UGT1A9), uridine diphosphate-glucuronosyltransferase 2B7 (UGT2B7), CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and P-gp will be monitored for potential adverse events based on the Epidiolex® label for the concomitant medication being used.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Epidiolex
150mg of Epidiolex
Placebo oral solution
150mg of Placebo oral solution

Locations

Country Name City State
United States Houston Methodist Hospital Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
The Methodist Hospital Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary - Pain Journal Evaluation of postoperative pain journal responses from subjects. The pain diary will track their pain level on a Visual Analogue Scale (VAS) and their documented pain medication usage. 2 weeks
Secondary Survey Data Evaluation of the survey data and questionnaires from baseline to the end of the two weeks post operative period. 2 weeks
Secondary Pain Disability Index (PDI) This survey is designed to measure the degree to which aspects of a participant's life are disrupted by chronic pain. Each item on the survey is rated on an eleven point scale from no disability (0) to worst disability (10). 2 weeks
Secondary Pain, Enjoyment, General Activity (PEG) Scale This survey tracks a participant's pain intensity and pain interference. Each item on the survey is rated on an eleven point scale from 0 to 10 with different measures at either end of the scale depending on which item (intensity or interference) is being evaluated. 2 weeks
Secondary Patient Health Questionnaire 4 (PHQ-4): The four-item patient health questionnaire for anxiety This survey measures how frequently a patient was bothered by symptoms of anxiety or depression. It is measured on a four point scale from 0-3 with each number corresponding to how often a patient experienced a symptom with 0 being not at all, and 3 being nearly every day. 2 weeks
Secondary Pittsburgh Sleep Quality Index (PSQI) This survey assesses the amount and quality of sleep that a patient has experienced in the last month. It is measured both with general free response questions and scaled questions reflecting frequency or lack thereof for a given issue (rated from Not during the past month to Three or more times a week). 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT06070493 - The Effects of Myofascial Release Technique N/A
Completed NCT04541953 - TeleRehabilitation Following Arthroscopic Rotator Cuff Repair N/A
Completed NCT04944446 - Myofascial Release in Shoulder Pathologies N/A
Recruiting NCT06112444 - Validity And Reliability Study Of The Turkish Version Of Short Western Ontario Rotator Cuff Index
Completed NCT04594408 - Tranexamic Acid to Improve Arthroscopic Visualization in Shoulder Surgery Phase 4
Active, not recruiting NCT04686396 - Demineralized Bone Matrix Rotator Cuff Study N/A
Recruiting NCT05988541 - Rotator Cuff Integrity and Clinical Outcomes 5 Years After Repair. N/A
Completed NCT04470167 - Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear Phase 1/Phase 2
Recruiting NCT05297305 - Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty N/A
Completed NCT02528084 - The Effects of Yoga on Patients With Rotator Cuff Injuries N/A
Recruiting NCT05011331 - The Effect of a Custom Pillow on Sleep Quality in Patients With Nonoperative Rotator Cuff Syndrome N/A
Recruiting NCT04209504 - Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block
Completed NCT03967574 - Subacromial Corticosteroid Injections and tDCS in Rotator Cuff Tendinopathy N/A
Not yet recruiting NCT05906004 - Retrospective Data Collection and Prospective Clinical Investigation for the Augmentation or Reinforcement of the Rotator Cuff Using the Pitch-Patch
Completed NCT04952623 - Online Education to Improve the Management of Rotator Cuff Related Shoulder Pain N/A
Recruiting NCT05344898 - Subscap Reverse Shoulder Arthroplasty N/A
Recruiting NCT04175184 - Inclusion of Mobilisation With Movement to an Exercise Programme in Rotator Cuff Related Pain N/A
Terminated NCT05215600 - Anaverse™ Glenoid System and Its Instrumentation
Recruiting NCT05822414 - ESP vs STB for Pain and Diagraphragm Function for Shoulder Surgery N/A
Completed NCT04833244 - Automatic Multimodal Assessment of Occurrence and Intensity of Pain for Research and Clinical Use N/A